- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05050266
Mejora de la salud mental y física de las mujeres veteranas (EMPOWER)
Mejorar la salud mental y física de las mujeres a través del compromiso y la retención (EMPOWER) QUERI 2.0 (QUE 20-028)
Women Veterans are the fastest growing segment of VA users. This dramatic growth has created challenges for VA to ensure that appropriate services are available to meet women Veterans' needs, and that they will want and be able to use those services. The EMPOWER QUERI 2.0 Program is a cluster randomized type 3 hybrid implementation-effectiveness trial testing two strategies designed to support implementation and sustainment of evidence-based practices for women Veterans in at least 20 VA facilities from 4 regions.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Women Veterans are the fastest-growing segment of users in the Veterans Health Administration (VA). Their numbers are projected to increase by 73%, from 9.3% to 16.4%, between 2015 and 2043. Despite VA investment in improving care for women Veterans, gender disparities persist in cardiovascular (CV) and diabetes risk factor control. Also, the rate of perinatal depression among women Veterans is higher than that among civilian women, which is of particular concern given the association between perinatal depression and suicidality. Barriers to care for women Veterans include distance to VA care, rurality, competing work and caregiving responsibilities, comorbid mental health issues, and harassment on VA grounds. Improvements are still needed to increase women Veterans' access to and engagement in convenient, safe, evidence-based, patient-centered care that achieves the VA "lane of effort" of Veterans' "lifelong health, well-being, and resilience."
Since its inception in 2015, the Enhancing Mental and Physical health of Women through Engagement and Retention (EMPOWER) QUERI 1.0 team has focused on implementing gender-tailored care models for women Veteran patients. In EMPOWER 1.0 studies, women expressed preferences for gender-specific (women only) care and for virtual care options. Therefore, the EMPOWER 2.0 Impact Goal is to expand access to virtual, evidence-based, preventive lifestyle and mental health services for women Veterans with high-priority health conditions in rural and urban-isolation areas. This cluster randomized type 3 hybrid implementation-effectiveness trial randomized 20 VA sites to one of two implementation strategies, the Replicating Effective Practices (REP) or Evidence-Based Quality Improvement (EBQI), to support implementation and sustainment of evidence-based practices (EBPs). The EBPs focus on preventive lifestyle and mental health care for women Veterans across VA facilities, several of which are rural, low-performing in women's health care, and/or lead sites for high reliability organization. The study team will conduct a mixed methods implementation evaluation to compare the effectiveness of REP and EBQI in terms of: (a) improved access to and rates of engagement in virtual preventive lifestyle and mental health services and improved VA performance metrics for virtual and telehealth care delivery and related clinical outcomes for women Veterans; (b) progression along the Stages of Implementation Completion; (c) adaptation, sense-making, and experiences of EBP implementation among multilevel stakeholders; and (d) cost and return on investment.
On 8/15/23, as part of our 12 month registration update corrected the primary outcomes to accurately reflect the randomized trial and analyses design. The cluster randomized trial will evaluate the effectiveness of two implementation strategies (REP and EBQI) in implementing evidence-based practices (EBPs) for preventive services. Although we are implementing three evidence-based practices (DPP, TLC and ROSE), the EBPs are combined for each of the trial's two primary outcomes (access and engagement).
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
California
-
West Los Angeles, California, Estados Unidos, 90073-1003
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
This study is recruiting VA sites - not individual patients. Prior to randomization, the study team will work with sites to ensure they have met the preconditions necessary to enroll in the study, which includes VISN, regional and/or facility level leadership support for participation.
Exclusion Criteria:
N/A
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: REP
Replicating Effective Practices (REP) is a lower-intensity implementation strategy with explicit process framework for local tailoring |
The REP framework consists of 4 phases: pre-conditions, pre-implementation, implementation and maintenance/evolution. REP has a strong evidence-base and application in VHA health services research in promoting uptake of EBPs. Sites randomized to REP will meet quarterly with the implementation support team (i.e., low-intensity). |
|
Experimental: EBQI
Evidence-Based Quality Improvement (EBQI) is a higher-intensity implementation strategy that entails external facilitation and formal training in quality improvement. |
EBQI is a systematic quality improvement method for engaging frontline practices in improvement that introduces "best science" and evidence in the service of operational goals. EBQI has been tested in several VA implementation trials. Sites randomized to EBQI will meet monthly with the implementation support team (i.e., high-intensity). |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Access to virtual care for preventive services
Periodo de tiempo: 12 months
|
Proportion of eligible women Veterans who enroll in virtual DPP, TLC, or ROSE at each site |
12 months
|
|
Engagement in virtual care for preventive services
Periodo de tiempo: 12 months
|
Proportion of eligible women Veterans who attend 1 or more virtual DPP, TLC, or ROSE sessions at each site |
12 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Participation and engagement: DPP
Periodo de tiempo: 6 and 12 months
|
average # of sessions attended by women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: DPP
Periodo de tiempo: 6 and 12 months
|
proportion who completed >9 and >16 sessions among women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: DPP
Periodo de tiempo: 6 and 12 months
|
% weight change among women Veterans who enrolled in DPP at each site |
6 and 12 months
|
|
Participation and engagement: TLC
Periodo de tiempo: 6 months
|
average # of TLC sessions completed among women Veterans who enrolled in TLC at each site |
6 months
|
|
Participation and engagement: TLC
Periodo de tiempo: 6 months
|
% with health behavioral goal among women Veterans who enrolled in TLC at each site |
6 months
|
|
Participation and engagement: TLC
Periodo de tiempo: 6 months
|
% with behavioral change (physical activity, diet: fruit, vegetable and sugary beverage intake, stress and coping, and weight) at each site |
6 months
|
|
Participation and engagement: ROSE
Periodo de tiempo: 6 months
|
average # of ROSE sessions completed at each site |
6 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Alison B Hamilton, PhD MPH, VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Publicaciones y enlaces útiles
Publicaciones Generales
- Finley EP, Hamilton AB, Canelo I, Jackson SS, Lesser R, Oberman RS, Yosef J, Chrystal JG, Fletcher EH, Bean-Mayberry B, Moin T, Farmer MM, Lang AJ. Collaborative tailoring of the Reach Out, Stay Strong Essentials (ROSE) program for pregnant veterans in the U.S. Veterans Health Administration: a qualitative case study of contextual conditions and adaptations. BMC Health Serv Res. 2025 May 23;25(1):746. doi: 10.1186/s12913-025-12871-x.
- Malone A, Clair K, Chanfreau C, Bean-Mayberry B, Oberman R, Lesser R, Knight C, Finley E, Hamilton A, Farmer MM, Moin T. Predictors of enrollment in a virtual diabetes prevention program among women veterans: a retrospective analysis. BMC Womens Health. 2024 Aug 24;24(1):465. doi: 10.1186/s12905-024-03314-6.
- Finley EP, Chrystal JG, Gable AR, Fletcher EH, Palma A, Canelo I, Oberman RS, Jackson SS, Lesser R, Moin T, Bean-Mayberry B, Farmer MM, Hamilton A. The Rapid Implementation Feedback (RIF) report: real-time synthesis of qualitative data for proactive implementation planning and tailoring. Implement Sci Commun. 2024 Jun 21;5(1):69. doi: 10.1186/s43058-024-00605-9.
- Hamilton AB, Finley EP, Bean-Mayberry B, Lang A, Haskell SG, Moin T, Farmer MM; EMPOWER QUERI Team. Enhancing Mental and Physical Health of Women through Engagement and Retention (EMPOWER) 2.0 QUERI: study protocol for a cluster-randomized hybrid type 3 effectiveness-implementation trial. Implement Sci Commun. 2023 Mar 8;4(1):23. doi: 10.1186/s43058-022-00389-w.
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
- Depresión
- Obesidad
- Salud mental
- Colesterol
- Hipertensión
- Mujeres
- Diabetes mellitus
- El embarazo
- De fumar
- Exceso de peso
- Veteranos
- Primeros auxilios
- Prevención
- Enfermedades cardiovasculares
- Preferencia del paciente
- Participación del paciente
- Comportamiento de salud
- Mejora de la calidad
- Satisfacción del paciente
- Estado prediabético
- Médicos, Atención Primaria
- Factores de riesgo de enfermedades del corazón
- Depresión, Posparto
- Médicos, Mujeres
Términos MeSH relevantes adicionales
- Enfermedades urogenitales
- Enfermedades del sistema endocrino
- Enfermedades Vasculares
- Desordenes mentales
- Trastornos Nutricionales
- Enfermedades urogenitales femeninas y complicaciones del embarazo
- Enfermedades metabólicas
- Sobrenutrición
- Peso corporal
- Complicaciones del embarazo
- Síntomas de comportamiento
- Trastornos del metabolismo de la glucosa
- Trastornos del estado de ánimo
- Trastornos Puerperales
- Desorden depresivo
- Condiciones Patológicas, Signos y Síntomas
- Comportamiento
- Enfermedades Nutricionales y Metabólicas
- Signos y síntomas
- Adherencia y Cumplimiento del Tratamiento
- Satisfacción personal
- Aceptación del paciente de la atención médica
- Exceso de peso
- Obesidad
- Hipertensión
- Enfermedades cardiovasculares
- Depresión
- Diabetes mellitus
- Depresión, Posparto
- Estado prediabético
- Bienestar psicológico
- De fumar
- Comportamiento de salud
- Participación del paciente
- Preferencia del paciente
- Satisfacción del paciente
Otros números de identificación del estudio
- QUX 21-006
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Data sets underlying all publications resulting from the proposed research will not be shared outside VA, except as required under the Freedom of Information Act (FOIA), because VHA policy would prohibit re-disclosure.
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .